Search Within

Paul Chapman

Formats
  1. Journal Article (206)
  2. Meeting Abstract (109)
  3. Book Section (8)
  4. Conference Paper (1)
  5. Editorial (1)
  6. Research Letter (1)
  7. Review (1)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (327)
  2. Department of Medicine (327)
  3. Melanoma and Immunotherapeutics Service (327)
  4. Solid Tumor Oncology Division (327)
  5. GSK Faculty (133)
  6. Melanoma Disease Management Team (93)

More Groups

People
  1. Jedd Wolchok (107)
  2. Katherine Panageas (77)
  3. Alan Houghton (60)
  4. Michael Postow (55)
  5. Margaret Callahan (50)
  6. Alexander Shoushtari (46)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2023 (8)
  4. 2022 (2)
  5. 2021 (9)
  6. 2020 (8)

More Years

Publications
  1. Journal of Clinical Oncology (88)
  2. Clinical Cancer Research (29)
  3. Cancer Research (15)
  4. Proceedings of the American Association for Cancer Research Annual Meeting (13)
  5. New England Journal of Medicine (11)
  6. Melanoma Research (10)

More Publications

Publishers
  1. American Society of Clinical Oncology (94)
  2. American Association for Cancer Research (60)
  3. Elsevier Inc. (22)
  4. Lippincott Williams & Wilkins (19)
  5. Wiley Blackwell (19)
  6. Oxford University Press (13)

More Publishers

Results (327)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Dermatological toxicities associated with MEK 1/2 inhibitor AZD6244
    Meeting Abstract

    Myskowski, P.; Balagula, Y.; Barth, K.; Busam, K.; Lacouture, M. E.; Chapman, P. B.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Early FDG-PET responses to PLX4032 in BRAF-mutant advanced melanoma
    Meeting Abstract

    McArthur, G. A.; Puzanov, I.; Ribas, A.; Chapman, P. B.; Kim, K. B.; Sosman, J. A.; Lee, R. J.; Nolop, K. B.; Flaherty, K. T.; Hicks, R.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • PLX4032 (RG7204), a selective mutant RAF inhibitor: Clinical and histologic characteristics of therapy-associated cutaneous neoplasms in a phase I trial
    Meeting Abstract

    Lacouture, M. E.; McArthur, G. A.; Chapman, P. B.; Ribas, A.; Flaherty, K. T.; Lee, R. J.; Nolop, K. B.; Kim, K. B.; Duvic, M.; Sosman, J. A.; more...
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Immunologic response to xenogeneic gp100 DNA in melanoma patients: Comparison of particle-mediated epidermal delivery with intramuscular injection
    Meeting Abstract

    Ginsberg, B. A.; Wolchok, J. D.; Roman, R.; Gallardo, H. F.; Chapman, P. B.; Schwartz, G. K.; Carvajal, R. D.; Terzulli, S. L.; Bewkes, B. B.; Yuan, J. D.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • The pan-RAF inhibitor PLX4032 inhibits ERK signaling and tumor cell proliferation in a V600E BRAF mutant-selective manner
    Meeting Abstract

    Joseph, E. W.; Pratilas, C. A.; Poulikakos, P. I.; Tadi, M.; Wang, W.; Taylor, B. S.; Persaud, Y.; Xing, F.; Halilovic, E.; Viale, A.; more...
    Cancer Research (2010)

    Fulltext@MSK | Save
  • Inhibition of mutated BRAF in melanoma - Reply
    Journal Article

    Flaherty, K. T.; Chapman, P. B.
    New England Journal of Medicine (2010)

    Fulltext@MSK | Save
  • The role of anti-tumor necrosis factor receptor agents in cancer survivors: Does the risk justify the benefit?
    Journal Article

    Chapman, P.; Cranmer, L.; Dixon, W. G.; Hyrich, K. L.; Patterson, J. R.; Symmons, D. P. M.; Toporcer, M.; Mastrangelo, M. J.
    Seminars in Oncology (2010)

    Fulltext@MSK | Save
  • Radiotherapy after surgical resection for head and neck mucosal melanoma
    Journal Article

    Wu, A. J.; Gomez, J.; Zhung, J. E.; Chan, K.; Gomez, D. R.; Wolden, S. L.; Zelefsky, M. J.; Wolchok, J. D.; Carvajal, R. D.; Chapman, P. B.; more...
    American Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Novel anti-idiotype antibody therapy for lipooligosaccharide-induced experimental autoimmune neuritis: Use relevant to Guillain-BarrĂ© syndrome
    Journal Article

    Usuki, S.; Taguchi, K.; Thompson, S. A.; Chapman, P. B.; Yu, R. K.
    Journal of Neuroscience Research (2010)

    Fulltext@MSK | Save
  • Phase II trial of neoadjuvant temozolomide in resectable melanoma patients
    Journal Article

    Shah, G. D.; Socci, N. D.; Gold, J. S.; Wolchok, J. D.; Carvajal, R. D.; Panageas, K. S.; Viale, A.; Brady, M. S.; Coit, D. G.; Chapman, P. B.
    Annals of Oncology (2010)

    Fulltext@MSK | Save